Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Response Monitoring Theta-Band Activities Across Emotional Contexts in Schizophrenia and Bipolar Spectrum Disorders

3 months 2 weeks ago
CONCLUSIONS: SZ and BD show different effects of emotional stimuli on cognitive control. To elucidate similarities and differences, concurrent data collection from individuals with SZ and BD across contexts is needed.
Takakuni Suzuki

Steroid-Dependent Nephrotic Syndrome in a Pediatric Patient With Type-1 Diabetes Mellitus

3 months 2 weeks ago
Proteinuria in a patient with long-standing Type 1 diabetes mellitus (T1DM) usually suggests diabetic kidney disease (DKD). However, DKD occurs late in the disease and is associated with hypertension and retinopathy. We report an adolescent with T1DM who, 1 year after initial diagnosis, developed nephrotic syndrome (NS). He was treated with steroids but developed frequent relapses and became steroid-dependent. A subsequent kidney biopsy revealed minimal change disease (MCD) and mild DKD. He was...
Nisha S Singh

Efficacy and Safety of Mycophenolate Mofetil Compared to Azathioprine in Autoimmune Hepatitis: A Meta-Analysis

3 months 2 weeks ago
CONCLUSIONS: MMF may be a suitable first-line alternative to AZA for AIH, with higher rates of BR, especially in patients intolerant or non-responsive to standard therapy. However, the long-term efficacy and safety of MMF requires further investigation through rigorous randomized controlled trials.
Shahryar Khan

Exploring #HealthLiteracy on LinkedIn: a first look at health hashtag engagement in a professional social media context

3 months 2 weeks ago
LinkedIn, despite its large and professionally credentialed user base, remains an underexplored platform for digital health communication, unlike X (formerly Twitter), which has been widely studied for health-related hashtag trends. Health literacy, a key determinant of public health, is increasingly promoted through social media hashtags such as #HealthLiteracy. However, to date, no studies have systematically examined how this hashtag is used on LinkedIn. This study aimed to analyze the use of...
Siva Sai Chandragiri

Clinical Outcomes After Proton Therapy Reirradiation for Recurrent Malignant Glioma: Analysis From the Prospective Proton Collaborative Group Registry

3 months 2 weeks ago
CONCLUSIONS: In the largest series of glioma PT-ReRT reported to date, retreatment was well tolerated with variable outcomes based on clinical prognostic factors. Toxicity rates were similar compared to photon-based literature despite a high median ReRT prescription dose.
Omer Gal

Pagination

  • Previous page ‹ Previous
  • Page 3
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2025. All rights reserved. Designed By Zymphonies